Dobashi, A.; Aizawa, D.; Hara, Y.; Furuhashi, H.; Matsui, H.; Futakuchi, T.; Ono, S.; Toyoizumi, H.; Bazerbachi, F.; Yamauchi, T.;
et al. The Advantage of Immunohistochemical Staining for Evaluating Lymphovascular Invasion Is Limited for Patients with Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa. J. Clin. Med. 2022, 11, 6969.
https://doi.org/10.3390/jcm11236969
AMA Style
Dobashi A, Aizawa D, Hara Y, Furuhashi H, Matsui H, Futakuchi T, Ono S, Toyoizumi H, Bazerbachi F, Yamauchi T,
et al. The Advantage of Immunohistochemical Staining for Evaluating Lymphovascular Invasion Is Limited for Patients with Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa. Journal of Clinical Medicine. 2022; 11(23):6969.
https://doi.org/10.3390/jcm11236969
Chicago/Turabian Style
Dobashi, Akira, Daisuke Aizawa, Yuko Hara, Hiroto Furuhashi, Hiroaki Matsui, Toshiki Futakuchi, Shingo Ono, Hirobumi Toyoizumi, Fateh Bazerbachi, Takashi Yamauchi,
and et al. 2022. "The Advantage of Immunohistochemical Staining for Evaluating Lymphovascular Invasion Is Limited for Patients with Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa" Journal of Clinical Medicine 11, no. 23: 6969.
https://doi.org/10.3390/jcm11236969
APA Style
Dobashi, A., Aizawa, D., Hara, Y., Furuhashi, H., Matsui, H., Futakuchi, T., Ono, S., Toyoizumi, H., Bazerbachi, F., Yamauchi, T., Suka, M., & Sumiyama, K.
(2022). The Advantage of Immunohistochemical Staining for Evaluating Lymphovascular Invasion Is Limited for Patients with Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa. Journal of Clinical Medicine, 11(23), 6969.
https://doi.org/10.3390/jcm11236969
